Drug Search Results
More Filters [+]

Carbachol

Alternative Names: carbachol, carbastat, miostat
Latest Update: 2024-08-22
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: mAChR Agonist,nAChR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Belgium | Brazil | Canada | Chile | Colombia | Czech | Dominican Republic | Ecuador | France | Germany | Hong Kong | Hungary | Ireland | Korea | Lebanon | Luxembourg | Malaysia | Mexico | Netherlands | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Russia | Singapore | Slovenia | Sweden | Switzerland | Taiwan | Thailand | Turkey | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Carbachol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title